MCL1 and T-cell non-Hodgkin lymphoma: However, we also observed that MCL-1 independent T-cell lymphoma cells were also sensitive to both AZD4573 (Fig. 2F, G) and an independent CDK9 antagonist [enitociclib [49], (Fig. 2H)].